Search research articles
Contact Us
Filters
Showing results (91-100 of 207) with videos related to
Page
of 21
Sort By:
Neuroimage
|
May 15, 2012
Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling
Andreas Hahn, Lukas Nics, Pia Baldinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 21, 2017
Impact of hybrid PET/MR technology on multiparametric imaging and treatment response assessment of cervix cancer
Michaela Daniel, Piotr Andrzejewski, Alina Sturdza, et al.
Nuclear Medicine and Biology
|
March 13, 2018
A new method measuring the interaction of radiotracers with the human P-glycoprotein (P-gp) transporter
Chrysoula Vraka, Monika Dumanic, Teresa Racz, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 17, 2014
Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease
Catharina Neudorfer, Karem Shanab, Andreas Jurik, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
October 23, 2020
Assessment of left and right ventricular functional parameters using dynamic dual-tracer [<sup>13</sup>N]NH3 and [<sup>18</sup>F]FDG PET/MRI
Sazan Rasul, Dietrich Beitzke, Tim Wollenweber, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 4, 2026
PET/MRI with <sup>89</sup>Zr-labelled antibodies provides insights into altered antibody pharmacokinetics in the chick embryo model
Katarína Benčurová, Daniel Gündel, Markus Kieler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 12, 2006
[18F]FETO: metabolic considerations
Dagmar E Ettlinger, Wolfgang Wadsak, Leonhard-Key Mien, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 30, 2019
Clinical outcome of standardized <sup>177</sup>Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks
Sazan Rasul, Marcus Hacker, Elisabeth Kretschmer-Chott, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 11, 2008
The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635
Patrycja Stein, Markus Savli, Wolfgang Wadsak, et al.
The Prostate
|
August 19, 2015
Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [(11) C]acetate PET as a prognostic marker
Asha Leisser, Konstatin Pruscha, Philipp Ubl, et al.
Page
of 21
Search research articles
Search
Showing results (91-100 of 207) with videos related to
Sort By:
Page
of 21
Neuroimage
|
May 15, 2012
Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling
Andreas Hahn, Lukas Nics, Pia Baldinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 21, 2017
Impact of hybrid PET/MR technology on multiparametric imaging and treatment response assessment of cervix cancer
Michaela Daniel, Piotr Andrzejewski, Alina Sturdza, et al.
Nuclear Medicine and Biology
|
March 13, 2018
A new method measuring the interaction of radiotracers with the human P-glycoprotein (P-gp) transporter
Chrysoula Vraka, Monika Dumanic, Teresa Racz, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 17, 2014
Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease
Catharina Neudorfer, Karem Shanab, Andreas Jurik, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
October 23, 2020
Assessment of left and right ventricular functional parameters using dynamic dual-tracer [<sup>13</sup>N]NH3 and [<sup>18</sup>F]FDG PET/MRI
Sazan Rasul, Dietrich Beitzke, Tim Wollenweber, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 4, 2026
PET/MRI with <sup>89</sup>Zr-labelled antibodies provides insights into altered antibody pharmacokinetics in the chick embryo model
Katarína Benčurová, Daniel Gündel, Markus Kieler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 12, 2006
[18F]FETO: metabolic considerations
Dagmar E Ettlinger, Wolfgang Wadsak, Leonhard-Key Mien, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 30, 2019
Clinical outcome of standardized <sup>177</sup>Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks
Sazan Rasul, Marcus Hacker, Elisabeth Kretschmer-Chott, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 11, 2008
The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635
Patrycja Stein, Markus Savli, Wolfgang Wadsak, et al.
The Prostate
|
August 19, 2015
Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [(11) C]acetate PET as a prognostic marker
Asha Leisser, Konstatin Pruscha, Philipp Ubl, et al.
Page
of 21